61.11 USD
▼+2.28-0.34%
盘后 61.32 0.00%
2026-08-03
市值
$2.63B
市盈率
—
EPS
-1.13
股息率
—
52 周区间
39.79 – 85.25
成交量
541.86K
Beta
0.52
目标价
94.44
52W 低 39.7952W 高 85.25
价格走势
公司简介
Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The company offers XDEMVY, a lotilaner ophthalmic solution for the treatment of demodex blepharitis caused by the infestation of Demodex mites. It sells its products to specialty pharmacies and distributors, as well as clinics, hospitals, pharmacies, and federal healthcare programs. The company also develops TP-04, a sterile aqueous gel formulation of lotilaner ...